Skip to main content

Seladelpar

Pronunciation: sell-a-dell-pah
Generic name: seladelpar
Brand name: Livdelzi
Dosage form: oral capsule

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 25, 2024.

What is seladelpar?

Seladelpar (Brand name Livdelzi) is an oral prescription medicine that may be used to treat primary biliary cholangitis (PBC) in adults. Seladelpar is:

It is not known if taking seladelpar will improve your chance of survival or prevent liver decompensation.

Seladelpar helps manage PBC by activating specific receptors that control key metabolic and liver disease pathways involved in bile acid synthesis; inflammation; fibrosis; and lipid metabolism, storage, and transport. Seladelpar is beneficial for PBC patients because it reduces bile acid production and helps counteract the liver damage caused by the buildup of bile acids.

Seladelpar gained FDA approval on August 14, 2024, as the brand name Livdelzi, under the accelerated approval designation. Continued approval may be contingent on a continued benefit being shown in clinical trials.

Seladelpar side effects

The most common side effects of seladelpar include:

Serious side effects and warnings

Seladelpar can cause the following serious side effects.

Bone fractures. Taking seladelpar may increase your risk of bone fractures. Tell your healthcare provider about any bone fractures, if you develop pain, or have changes in your ability to move around.

Changes in liver tests. Increased liver enzymes in the blood have happened when taking more seladelpar than prescribed. Your healthcare provider will do tests to check your liver before you start and during treatment with seladelpar. Tell your healthcare provider right away if you have any of the following signs or symptoms of worsening liver problems during treatment with seladelpar:

It is not known if seladelpar is safe and effective in children.

Tell your healthcare provider if you have any side effect that bothers you or does not go away. These are not all the possible side effects of seladelpar. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before taking

Seladelpar is not recommended for use in people who have advanced liver disease (decompensated cirrhosis). Symptoms of advanced liver disease may include:

Before taking seladelpar, tell your healthcare provider about all your medical conditions, including if you:

Pregnancy

It is not known if seladelpar will harm an unborn baby. If you become pregnant while taking seladelpar, tell your healthcare provider right away. There is a pregnancy safety study for women who take seladelpar during pregnancy. Talk to your healthcare provider about providing information about the seladelpar pregnancy safety study. The purpose of this pregnancy safety study is to capture information about your health and your baby’s health. You or your healthcare provider can report your pregnancy by calling 1-800-445-3235.

Breastfeeding

It is not known if seladelpar passes into your breast milk. Talk with your healthcare provider about the best way to feed your baby if you take seladelpar.

How should I take seladelpar?

Take seladelpar exactly as your healthcare provider tells you to. Do not take more seladelpar than your healthcare provider tells you to.

Seladelpar dosage

Usual adult dosage of seladelpar for PBC

What happens if I overdose

If you take too much seladelpar, call your healthcare provider or get emergency medical help right away.

What other drugs will affect seladelpar?

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. seladelpar can affect the way certain medicines work. Certain other medicines may affect the way seladelpar works. Especially tell your healthcare provider if you take:

Seladelpar should be taken at least 4 hours before or 4 hours after you take medicines to help lower your cholesterol called bile acid-binding resins (examples include cholestyramine or colestipol). If this is not possible, space the time between taking seladelpar and your bile acid-binding resin as far apart as possible.

This is not a complete list of interactions. See the seladelpar Package Insert for a full list.

Storage

Store seladelpar at room temperature between 68°F to 77°F (20°C to 25°C).

Keep out of the reach of children.

Ingredients

Seladelpar is only available unde the brand name Livdelzi. There is not Livdelzi generic.

Active ingredient: seladelpar lysine

Inactive ingredients: butylated hydroxytoluene, colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, mannitol, microcrystalline cellulose, and hard gelatin shells.

Capsule shells contain gelatin, titanium dioxide, black iron oxide, yellow iron oxide, red iron oxide, and the colorant FD&C Blue #2.

Seladelpar is available in 10 mg capsules.

Who makes seladelpar?

Gilead Sciences, Inc. manufactures seladelpar as the brand name Livdelzi.

More about seladelpar

Patient resources

Other brands

Livdelzi

Professional resources

Other brands

Livdelzi

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.